A.S. Kalogirou et al. / Tetrahedron xxx (2014) 1e10
7
34), 210 (14), 178 (4), 146 (100), 120 (9), 102 (8), 94 (41), 70 (12),
64 (38), 53 (10). Found Mþ, 244.9489. C7H4ClN3OS2 requires M,
244.9484. Further elution (DCM) gave (E)-6-(4-chloro-5H-1,2,3-
dithiazol-5-ylidene)-2-[(Z)-(4-chloro-5H-1,2,3-dithiazol-5-ylidene)
amino]pyridin-3(6H)-one (13) as a blue dust (2.7 mg, 3%), mp
288e289 ꢀC (from DCE); Rf 0.41 (DCM). Found C, 28.51; H, 0.50;
N, 15.02. C9H2Cl2N4OS4 requires C, 28.35; H, 0.53; N, 14.69%; lmax
2.63), 327 (2.57), 418 (2.68); nmax/cmꢁ1 2257w (C^N), 1609m,
1599m, 1524m, 1476w, 1400s, 1362w, 1333s, 1279m, 1231s, 1167w,
1153m, 1117w, 1032w, 1005w, 993w, 953m, 901m, 845w, 829s,
816s, 806s, 773s; dH (300 MHz; CDCl3) 8.63 (1H, dd, J 1.5, 4.8, Py H-4
or 6), 8.26 (1H, dd, J 1.65, 7.95, Py H-6 or 4), 7.56 (1H, dd, J 4.8, 8.1, Py
H-5); dC (75 MHz; CDCl3) 158.3 (s), 149.3 (d), 137.5 (s),131.2 (s), 131.1
(d), 122.9 (d), 108.6 (s); m/z (EI) 145 (Mþ, 100%), 117 (82), 65 (35), 64
(20), 54 (8), 51 (4).
(DCM)/nm 260 (log
3
2.34), 268 (2.32), 331 (1.81), 418 (1.74), 615
(2.09); nmax/cmꢁ1 2922w, 2847w, 1570w, 1503m, 1485m, 1447m,
1424m, 1367w, 1360w, 1325s, 1288m, 1240s, 1209m, 1105w,
1047m, 941w, 914w, 883m, 851w, 824m, 808w, 789m, 779m; dH
(500 MHz; TFA-d1) 9.23 (1H, J 6.0, Py H), 8.08 (1H, J 5.5, Py H); dC
(125 MHz; TFA-d1) 164.4 (s), 162.9 (s), 155.5 (s), 146.3 (s), 141.0 (s),
129.6 (d), 129.3 (s), 119.9 (d); m/z (EI) 384 (Mþþ4, 7%), 382
(Mþþ2, 22), 380 (Mþ, 25), 347 (13), 345 (MþꢁCl, 25), 310 (4), 283
(39), 281 (100), 253 (5), 231 (14), 229 (33), 220 (4), 214 (4), 192
(3), 166 (10), 160 (7), 142 (8), 140 (14), 137 (7), 134 (11), 102 (14),
99 (11), 96 (16), 85 (11), 82 (17), 76 (18), 70 (21), 64 (80), 57 (14).
Further elution (DCM/t-BuOMe, 9:1) gave (E)-2-amino-6-(4-
chloro-5H-1,2,3-dithiazol-5-ylidene)pyridin-3(6H)-one (14) as lus-
trous bronze coloured prisms (2.4 mg, 4%), mp (DSC) onset:
156.6 ꢀC peak max: 168.5 ꢀC (decomp.) (from DCE); Rf 0.53 (DCM/
t-BuOMe, 9:1). Found: C, 34.37; H, 1.72; N, 16.97. C7H4ClN3OS2
4.3.3. Thermolysis of 2-(4-chloro-5H-1,2,3-dithiazol-5-
ylideneamino)pyridin-3-ol (5c). Similar treatment of 2-(4-chloro-
5H-1,2,3-dithiazol-5-ylideneamino)pyridin-3-ol (5c) (49.2 mg,
0.20 mmol) gave S8 (12.2 mg, 95%) and oxazolo[4,5-b]pyridine-2-
carbonitrile (4c) (20.9 mg, 72%) as colourless needles, mp
49e50 ꢀC (from c-hexane); Rf 0.20 (n-hexane/DCM, 4:6). Found C,
57.86; H, 2.10; N, 28.88. C7H3N3O requires C, 57.94; H, 2.08; N,
28.96%; lmax (DCM)/nm 245 (log 2.63), 292 (3.09), 304 inf (2.89);
3
nmax/cmꢁ1 3043w, 2259w (C^N), 1715w, 1700w, 1684w, 1653w,
1611m, 1537m, 1506w, 1403s, 1321m, 1293w, 1260m, 1251w,
1223m, 1212w, 1171m, 1111w, 1030m, 954m, 844m, 828m, 795s,
780s; dH (300 MHz; CDCl3) 8.80 (1H, d, J 4.45, Py H-4 or 6), 8.04 (1h,
dd, J 1.4, 8.4, Py H-6 or 4), 7.59 (1H, dd, J 4.7, 8.4, Py H-5); dC
(75 MHz; CDCl3) 152.4 (s), 149.6 (d), 143.2 (s), 139.6 (s), 123.8 (d),
120.0 (d), 108.5 (s); m/z (EI) 145 (Mþ, 98%), 94 (6), 93 (100), 65 (49),
64 (23).
requires C, 34.22; H, 1.64; N, 17.10%; lmax (DCM)/nm 281 (log
3.73), 298 inf (3.66), 422 inf (3.21), 549 (4.19); nmax/cmꢁ1 3486w
and 3300m (NH2), 3215w, 1612w, 1554m, 1541s, 1511s, 1449m,
1428s, 1407s, 1365s, 1333w, 1318m, 1235s, 1206m, 1139m, 1079m,
960w, 875m, 831m, 812s, 753w; dH (500 MHz; DMSO-d6) 8.51
(1H, J 9.5, Py H), 7.49 (1H, br s, NH2), 7.06 (1H, br s, NH2), 6.34 (1H,
J 9.0, Py H); dC (125 MHz; DMSO-d6) 173.9 (s), 154.2 (s), 147.4 (s),
141.4 (s), 135.6 (s), 127.9 (d), 121.0 (d); m/z (EI) 247 (Mþþ2, 28%),
245 (Mþ, 64), 217 (4), 210 (14), 182 (13), 178 (28), 175 (35), 156 (8),
150 (5), 140 (14), 124 (9), 110 (16), 104 (35), 96 (31), 93 (31), 82
(80), 76 (84), 70 (60), 64 (100), 53 (37).
3
4.4. Solvent-free thermolysis of 2-hydroxy-(4-chloro-5H-
1,2,3-dithiazol-5-ylideneamino)arenes
4.4.1. Thermolysis of 2-(4-chloro-5H-1,2,3-dithiazol-5-ylideneamino)
phenol (5a) (typical procedure: see Table 1). Neat 2-(4-chloro-5H-
1,2,3-dithiazol-5-ylideneamino)phenol
(5a)
(48.8
mg,
0.20 mmol) was heated at ca. 200 ꢀC for 1 min in argon atmo-
sphere. On cooling to ca. 20 ꢀC the reaction mixture was adsor-
bed onto silica and chromatography (n-hexane) gave S8 (4.7 mg,
60%). Further elution (n-hexane/DCM, 6:4) gave benzo[d]oxazole-
2-carbonitrile (4a) (24.7 mg, 85%) as colourless needles, mp
99e100 ꢀC (lit.39 102e104 ꢀC) (from c-hexane), identical to that
described above.
4.3. Thermolysis of 2-hydroxy-(4-chloro-5H-1,2,3-dithiazol-5-
ylideneamino)arenes in PhCl at reflux
4.3.1. Thermolysis of 2-(4-chloro-5H-1,2,3-dithiazol-5-ylideneamino)
phenol (5a) (typical procedure: see Table 1). A stirred solution of 2-
4.4.2. Thermolysis of 3-(4-chloro-5H-1,2,3-dithiazol-5-
ylideneamino)pyridin-2-ol (5b). Similar treatment of 3-(4-chloro-
5H-1,2,3-dithiazol-5-ylideneamino)pyridin-2-ol (5b) (49.2 mg,
0.20 mmol) at ca. 200 ꢀC for 2 min gave S8 (11.5 mg, 90%). Further
elution (n-hexane/DCM, 4:6) gave oxazolo[5,4-b]pyridine-2-
carbonitrile (4b) (19.1 mg, 66%) as colourless needles, mp
105e106 ꢀC (from c-hexane), identical to that described above.
Further elution (DCM) gave [1,2,3]dithiazolo[5,4-e]pyrido[3,2-b][1,4]
oxazine 6b (0.4 mg, 1%) as orange fibres, mp 217e218 ꢀC (from c-
hexane/EtOH); Rf 0.32 (DCM). Found C, 40.26; H, 1.40; N, 20.09.
C7H3N3OS2 requires C, 40.18; H,1.45; N, 20.08%; lmax (DCM)/nm 272
(4-chloro-5H-1,2,3-dithiazol-5-ylideneamino)phenol
(5a)
(48.8 mg, 0.20 mmol) in PhCl (2 mL) was heated at ca. 132 ꢀC,
until no starting materials remained (TLC, 15 h). On cooling to ca.
20 ꢀC the reaction mixture was adsorbed onto silica and chro-
matography (n-hexane) gave S8 (12.5 mg, 98%). Further elution
(n-hexane/DCM, 6:4) gave benzo[d]oxazole-2-carbonitrile (4a)
(23.9 mg, 83%) as colourless needles, mp 99e100 ꢀC (lit.39
102e104 ꢀC) (from c-hexane); Rf 0.57 (n-hexane/DCM, 6:4);
lmax (DCM)/nm 273 inf (log
3
3.19); nmax/cmꢁ1 2251m (C^N),
1794w, 1611m, 1603m, 1530m, 1476m, 1445s, 1429w, 1371w,
1341s, 1287w, 1275w, 1258m, 1233w, 1219w, 1171s, 1163w, 1136w,
1105m, 993m, 953s, 895m, 953s, 895m, 854w, 837w, 818s, 760s;
dH (300 MHz; CDCl3) 7.90e7.86 (1H, m, Ph H), 7.67e7.49 (3H, m,
Ph H); dC (75 MHz; CDCl3) 150.3 (s), 139.4 (s), 137.2 (s), 129.1 (d),
126.5 (d), 121.9 (d), 111.5 (d), 109.1 (s); m/z (EI) 144 (Mþ, 100%),
116 (8), 92 (120), 64 (35).
inf (log 2.45), 308 (2.35), 383 inf (3.02), 411 (3.17), 434 inf (3.04);
3
nmax/cmꢁ1 3044w, 3007w, 1582m, 1562s, 1501s, 1423s, 1287m,
1269w, 1234s, 1192m, 1123m, 1076m, 1045m, 982w, 932m, 856w,
806s, 756s, 727m; dH (300 MHz; DMSO-d6) 7.92 (1H, d, J 4.1, Py H),
7.52 (1H, d, J 7.3, Py H), 7.14 (1H, dd, J 5.0, 7.0, Py H); dC (75 MHz;
DMSO-d6) 166.2 (s), 152.4 (s), 150.5 (s), 144.3 (d), 133.4 (d), 127.8 (s),
122.4 (d); m/z (EI) 209 (Mþ, 100%), 135 (54), 108 (17), 103 (10), 76
(13), 70 (16), 64 (24). Found Mþ, 208.9718. C7H3N3OS2 requires M,
208.9718.
4.3.2. Thermolysis of 3-(4-chloro-5H-1,2,3-dithiazol-5-
ylideneamino)pyridin-2-ol (5b). Similar treatment of 3-(4-chloro-
5H-1,2,3-dithiazol-5-ylideneamino)pyridin-2-ol (5b) (49.2 mg,
0.20 mmol) gave S8 (12.8 mg, 100%). Further elution (n-hexane/
DCM, 4:6) gave oxazolo[5,4-b]pyridine-2-carbonitrile (4b) (27.8 mg,
96%) as colourless needles, mp 105e106 ꢀC (from c-hexane); Rf 0.67
(n-hexane/DCM, 4:6). Found C, 57.86; H, 2.10; N, 28.88. C7H3N3O
4.4.3. Thermolysis of 2-(4-chloro-5H-1,2,3-dithiazol-5-
ylideneamino)pyridin-3-ol (5c). Similar treatment of 2-(4-chloro-
5H-1,2,3-dithiazol-5-ylideneamino)pyridin-3-ol (5c) (49.2 mg,
0.20 mmol) at ca. 200 ꢀC for 5 min gave S8 (11.5 mg, 90%) and
requires C, 57.94; H, 2.08; N, 28.96%; lmax (DCM)/nm 247 inf (log
3